Pricing Log in Create free account

Integra LifeSciences Holdings Corporation (IART) vs SiBone (SIBN)

Integra LifeSciences Holdings Corporation and SiBone are both Medical Devices companies. Integra LifeSciences Holdings Corporation is the larger, with a market value of $1.1B against $892.3M — 1.2× the size. SiBone grew revenue faster over the last twelve months: 15.3% against 1.60%. Integra LifeSciences Holdings Corporation has the higher net margin (−0.44% vs −6.85%) and the higher return on invested capital (1.58% vs −15.4%). Across the 18 metrics below, Integra LifeSciences Holdings Corporation leads on 12 and SiBone on 6.

Valuation

Metric IART SIBN Medical Devices median
P/E n/m n/m 23.22
P/S 0.62 4.10 2.34
P/B 0.98 4.80 2.33
Price to free cash flow 39.57 n/m 23.72
EV/EBITDA 11.92 n/m 11.54
EV/Sales 1.62 3.59 2.24
Earnings yield (0.68%) (1.73%) (10.09%)
Free cash flow yield 2.53% (0.50%) (8.47%)

Profitability

Metric IART SIBN Medical Devices median
Gross margin 52.47% 79.53% 56.01%
Operating margin 3.98% (8.31%) (15.03%)
Net margin (0.44%) (6.85%) (20.40%)
Free cash flow margin 1.57% (2.05%) (7.24%)
Return on equity (0.70%) (8.30%) (15.32%)
Return on assets (0.20%) (6.10%) (19.72%)
Return on invested capital 1.58% (15.40%) (10.33%)

Growth

Metric IART SIBN Medical Devices median
Revenue growth (TTM) 1.60% 15.30% 8.80%
EPS growth (last fiscal year) (7,388.89%) 41.33% 29.03%
Revenue growth, 5-year CAGR 3.57% 22.32% 15.47%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric IART SIBN Medical Devices median
Debt to equity 1.75 0.20 0.07
Current ratio 3.60 9.15 2.50
Net debt to EBITDA (4.62) 5.76 0.49

Dividend

Metric IART SIBN Medical Devices median
Dividend yield — — 1.16%
Payout ratio — — 0.36

Size

Metric IART SIBN Medical Devices median
Market cap 1.05b 892.34m 167.06m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack